chr21-44533935-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_144991.3(TSPEAR):c.304-12C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000946 in 1,604,490 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0020 ( 2 hom., cov: 28)
Exomes 𝑓: 0.00084 ( 6 hom. )
Consequence
TSPEAR
NM_144991.3 intron
NM_144991.3 intron
Scores
2
Splicing: ADA: 0.00001879
2
Clinical Significance
Conservation
PhyloP100: 0.283
Genes affected
TSPEAR (HGNC:1268): (thrombospondin type laminin G domain and EAR repeats) This gene encodes a protein that contains a N-terminal thrombospondin-type laminin G domain and several tandem arranged epilepsy-associated repeats (EARs). A mutation in this gene is the cause of autosomal recessive deafness-98. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 21-44533935-G-A is Benign according to our data. Variant chr21-44533935-G-A is described in ClinVar as [Benign]. Clinvar id is 504831.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00084 (1220/1453198) while in subpopulation MID AF= 0.0235 (134/5706). AF 95% confidence interval is 0.0202. There are 6 homozygotes in gnomad4_exome. There are 604 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPEAR | NM_144991.3 | c.304-12C>T | intron_variant | ENST00000323084.9 | NP_659428.2 | |||
TSPEAR | NM_001272037.2 | c.100-12C>T | intron_variant | NP_001258966.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPEAR | ENST00000323084.9 | c.304-12C>T | intron_variant | 1 | NM_144991.3 | ENSP00000321987.4 | ||||
TSPEAR | ENST00000397916.1 | n.259-12C>T | intron_variant | 1 | ||||||
TSPEAR | ENST00000642437.1 | n.*249-12C>T | intron_variant | ENSP00000496535.1 |
Frequencies
GnomAD3 genomes AF: 0.00192 AC: 290AN: 151174Hom.: 1 Cov.: 28
GnomAD3 genomes
AF:
AC:
290
AN:
151174
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00113 AC: 270AN: 238964Hom.: 0 AF XY: 0.00110 AC XY: 144AN XY: 130820
GnomAD3 exomes
AF:
AC:
270
AN:
238964
Hom.:
AF XY:
AC XY:
144
AN XY:
130820
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000840 AC: 1220AN: 1453198Hom.: 6 Cov.: 31 AF XY: 0.000836 AC XY: 604AN XY: 722274
GnomAD4 exome
AF:
AC:
1220
AN:
1453198
Hom.:
Cov.:
31
AF XY:
AC XY:
604
AN XY:
722274
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00197 AC: 298AN: 151292Hom.: 2 Cov.: 28 AF XY: 0.00198 AC XY: 146AN XY: 73864
GnomAD4 genome
AF:
AC:
298
AN:
151292
Hom.:
Cov.:
28
AF XY:
AC XY:
146
AN XY:
73864
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 25, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | 304-12C>T in intron 2 of TSPEAR: This variant is not expected to have clinical s ignificance because it has been identified in 0.5% (21/4386) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs192955018). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at